<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> may play and important role in the pathogenesis of <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e>; investigated the prevalence among 33 patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> vein and <z:mp ids='MP_0006134'>artery occlusions</z:mp> and 80 controls </plain></SENT>
<SENT sid="1" pm="."><plain>Prevalence was 33% and 5% respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Ophthalmic examination and <z:chebi fb="0" ids="31624">fluorescein</z:chebi> angiography showed that occlusions were due to ischaemic events </plain></SENT>
<SENT sid="3" pm="."><plain>The 11 patients were diagnosed with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>: 9 patients were treated successfully with laser photocoagulation and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anti-aggregant therapy </plain></SENT>
<SENT sid="4" pm="."><plain>Two patients with <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> associated with resistance to activated protein C had unfavourable outcomes </plain></SENT>
<SENT sid="5" pm="."><plain>Our results suggest a correlation between <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> and <z:chebi fb="46" ids="15035">retinal</z:chebi> vein occlusions; we recommend a systematic search for <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in occlusions of unexplained origin and laser photocoagulation treatment and long-term oral <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anti-aggregant therapy </plain></SENT>
</text></document>